5-HT2A Receptor and 5-HT Degradation Play a Crucial Role in Atherosclerosis by Modulating Macrophage Foam Cell Formation, Vascular Endothelial Cell Inflammation, and Hepatic Steatosis
Authors:
Open Access
- 1 March 2022
- journal article
- research article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 29 (3) , 322-336
Abstract
Aim: Previously, we found that diabetes-related liver dysfunction is due to activation of the 5-HT2A receptor (5-HT2AR) and increased synthesis and degradation of 5-HT. Here, we investigated the role of 5-HT in the development of atherosclerosis. Methods: The study was conducted using high-fat diet-fed male ApoE-/- mice, THP-1 cell-derived macrophages, and HUVECs. Protein expression and biochemical indexes were determined by Western blotting and quantitative analysis kit, respectively. The following staining methods were used: oil red O staining (showing atherosclerotic plaques and intracellular lipid droplets), immunohistochemistry (showing the expression of 5-HT2AR, 5-HT synthase, and CD68 in the aortic wall), and fluorescent probe staining (showing intracellular ROS). Results: In addition to improving hepatic steatosis, insulin resistance, and dyslipidemia, co-treatment with a 5-HT synthesis inhibitor and a 5-HT2AR antagonist significantly suppressed the formation of atherosclerotic plaques and macrophage infiltration in the aorta of ApoE-/- mice in a synergistic manner. Macrophages and HUVECs exposed to oxLDL or palmitic acid in vitro showed that activated 5-HT2AR regulated TG synthesis and oxLDL uptake by activating PKCε, resulting in formation of lipid droplets and even foam cells; ROS production was due to the increase of both intracellular 5-HT synthesis and mitochondrial MAO-A-catalyzed 5-HT degradation, which leads to the activation of NF-κB and the release of the inflammatory cytokines TNF-α and IL-1β from macrophages and HUVECs as well as MCP-1 release from HUVECs. Conclusion: Similar to hepatic steatosis, the pathogenesis of lipid-induced atherosclerosis is associated with activation of intracellular 5-HT2AR, 5-HT synthesis, and 5-HT degradation.Keywords
This publication has 34 references indexed in Scilit:
- Sarpogrelate protects against high glucose-induced endothelial dysfunction and oxidative stressInternational Journal of Cardiology, 2011
- The immune system in atherosclerosisNature Immunology, 2011
- Targeting the murine serotonin transporter: insights into human neurobiologyNature Reviews Neuroscience, 2008
- Mitochondrial reactive oxygen species-mediated signaling in endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated withl-thyroxin-induced hyperthyroidism — an experimental studyCanadian Journal of Physiology and Pharmacology, 2007
- Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxisJournal of Leukocyte Biology, 2006
- Serotonin acts as an up-regulator of acyl-coenzyme A:cholesterol acyltransferase-1 in human monocyte–macrophagesAtherosclerosis, 2006
- A new method for assessment of an anti‐5HT2A agent, sarpogrelate hydrochloride, on platelet aggregationJournal of Thrombosis and Haemostasis, 2006
- Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in MacrophagesJournal of Biological Chemistry, 2002
- Effects of serotonin-receptor blockade on angioplasty-induced vasospasm in an atherosclerotic rabbit model.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991